lithium-chloride and lysophosphatidic-acid

lithium-chloride has been researched along with lysophosphatidic-acid* in 1 studies

Other Studies

1 other study(ies) available for lithium-chloride and lysophosphatidic-acid

ArticleYear
Glycogen synthase kinase 3beta is a negative regulator of growth factor-induced activation of the c-Jun N-terminal kinase.
    The Journal of biological chemistry, 2004, Dec-03, Volume: 279, Issue:49

    The c-Jun N-terminal kinase (JNK)/stress activated protein kinase is preferentially activated by stress stimuli. Growth factors, particularly ligands for G protein-coupled receptors, usually induce only modest JNK activation, although they may trigger marked activation of the related extracellular signal-regulated kinase. In the present study, we demonstrated that homozygous disruption of glycogen synthase kinase 3beta (GSK-3beta) dramatically sensitized mouse embryonic fibroblasts (MEFs) to JNK activation induced by lysophosphatidic acid (LPA) and sphingosine-1-phosphate, two prototype ligands for G protein-coupled receptors. To a lesser degree, a lack of GSK-3beta also potentiated JNK activation in response to epidermal growth factor. In contrast, the absence of GSK-3beta decreased UV light-induced JNK activation. The increased JNK activation induced by LPA in GSK-3beta null MEFs was insufficient to trigger apoptotic cell death or growth inhibition. Instead, the increased JNK activation observed in GSK-3beta-/- MEFs was associated with an increased proliferative response to LPA, which was reduced by the inhibition of JNK. Ectopic expression of GSK-3beta in GSK-3beta-negative MEFs restrained LPA-triggered JNK phosphorylation and induced a concomitant decrease in the mitogenic response to LPA compatible with GSK-3beta through the inhibition of JNK activation, thus limiting LPA-induced cell proliferation. Mutation analysis indicated that GSK-3beta kinase activity was required for GSK-3beta to optimally inhibit LPA-stimulated JNK activation. Thus GSK-3beta serves as a physiological switch to specifically repress JNK activation in response to LPA, sphingosine-1-phosphate, or the epidermal growth factor. These results reveal a novel role for GSK-3beta in signal transduction and cellular responses to growth factors.

    Topics: 3T3 Cells; Animals; Apoptosis; Blotting, Western; Cells, Cultured; Cytoplasm; DNA Mutational Analysis; Dose-Response Relationship, Drug; Enzyme Activation; Epidermal Growth Factor; Fibroblasts; Genetic Vectors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Growth Substances; Homozygote; JNK Mitogen-Activated Protein Kinases; Ligands; Lithium Chloride; Lysophospholipids; Mice; Mitogen-Activated Protein Kinase 3; Mutation; Phosphorylation; Propidium; Protein Structure, Tertiary; Retroviridae; Signal Transduction; Sphingosine; Thymidine; Time Factors; Ultraviolet Rays

2004